Arantxa Baraibar Churio

Dr. Arantxa Baraibar Churio


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2021 in Life
Verified
Journal Article
Open access
PDF file
ACArantxa Baraibar Churio
Arantxa Baraibar Churio
MBMiriam Bobadilla
Miriam Bobadilla
FMFlorêncio de Jesus Duarte Mendes Machado
Florêncio de Jesus Duarte Mendes Machado
NSNeira Sáinz
Neira Sáinz
CRCarmen Roncal
Carmen Roncal
APAna Pérez
Ana Pérez
Matrix metalloproteinases (MMPs) have been implicated in the progression of muscular dystrophy, and recent studies have reported the role of MMP-10 in skeletal muscle pathology of young dystrophic mice. Nevertheless, its involvement in dystrophin-deficient hearts remains unexplored. Here, we aimed to investigate the involvement of MMP-10 in the progression of severe muscular dystrophy and to characterize MMP-10 loss in skeletal and cardiac muscles of aged dystrophic mice. We examined the histopathological effect of MMP-10 ablation in aged mdx mice, both in the hind limb muscles and heart tissues. We found that MMP-10 loss compromises survival rates of aged mdx mice, with skeletal and cardiac muscles developing a chronic inflammatory response. Our findings indicate that MMP-10 is implicated in severe muscular dystrophy progression, thus identifying a new area of research that could lead to future therapies for dystrophic muscles.

Verified
Journal Article
Open access
PDF file
GAGloria Abizanda
Gloria Abizanda
LLLeyre López-Muneta
Leyre López-Muneta
JLJavier Linares
Javier Linares
LRLuis I. Ramos
Luis I. Ramos
ACArantxa Baraibar Churio
Arantxa Baraibar Churio
Xonia Carvajal-VergaraXonia Carvajal-Vergara
Xonia Carvajal-Vergara
The success of cell therapy for the treatment of myocardial infarction depends on finding novel approaches that can substantially implement the engraftment of the transplanted cells. In order to enhance cell engraftment, most studies have focused on the pretreatment of transplantable cells. Here we have considered an alternative approach that involves the preconditioning of infarcted heart tissue to reduce endogenous cell activity and thus provide an advantage to our exogenous cells. This treatment is routinely used in other tissues such as bone marrow and skeletal muscle to improve cell engraftment, but it has never been taken in cardiac tissue. To avoid long-term cardiotoxicity induced by full heart irradiation we developed a rat model of a catheter-based heart irradiation system to locally impact a delimited region of the infarcted cardiac tissue. As proof of concept, we transferred ZsGreen+ iPSCs in the infarcted heart, due to their ease of use and detection. We found a very significant increase in cell engraftment in preirradiated rats. In this study, we demonstrate for the first time that preconditioning the infarcted cardiac tissue with local irradiation can substantially enhance cell engraftment.